240 related articles for article (PubMed ID: 32817625)
1. Down-regulation of tenascin-C inhibits breast cancer cells development by cell growth, migration, and adhesion impairment.
Wawrzyniak D; Grabowska M; Głodowicz P; Kuczyński K; Kuczyńska B; Fedoruk-Wyszomirska A; Rolle K
PLoS One; 2020; 15(8):e0237889. PubMed ID: 32817625
[TBL] [Abstract][Full Text] [Related]
2. Tenascin C induces epithelial-mesenchymal transition-like change accompanied by SRC activation and focal adhesion kinase phosphorylation in human breast cancer cells.
Nagaharu K; Zhang X; Yoshida T; Katoh D; Hanamura N; Kozuka Y; Ogawa T; Shiraishi T; Imanaka-Yoshida K
Am J Pathol; 2011 Feb; 178(2):754-63. PubMed ID: 21281808
[TBL] [Abstract][Full Text] [Related]
3. Tumor-derived tenascin-C promotes the epithelial-mesenchymal transition in colorectal cancer cells.
Takahashi Y; Sawada G; Kurashige J; Matsumura T; Uchi R; Ueo H; Ishibashi M; Takano Y; Akiyoshi S; Iwaya T; Eguchi H; Sudo T; Sugimachi K; Yamamoto H; Doki Y; Mori M; Mimori K
Anticancer Res; 2013 May; 33(5):1927-34. PubMed ID: 23645740
[TBL] [Abstract][Full Text] [Related]
4. Tumour-associated tenascin-C isoforms promote breast cancer cell invasion and growth by matrix metalloproteinase-dependent and independent mechanisms.
Hancox RA; Allen MD; Holliday DL; Edwards DR; Pennington CJ; Guttery DS; Shaw JA; Walker RA; Pringle JH; Jones JL
Breast Cancer Res; 2009; 11(2):R24. PubMed ID: 19405959
[TBL] [Abstract][Full Text] [Related]
5. Isochlorogenic Acid C Reverses Epithelial-Mesenchymal Transition
Yu JK; Yue CH; Pan YR; Chiu YW; Liu JY; Lin KI; Lee CJ
Anticancer Res; 2018 Apr; 38(4):2127-2135. PubMed ID: 29599331
[TBL] [Abstract][Full Text] [Related]
6. Association of invasion-promoting tenascin-C additional domains with breast cancers in young women.
Guttery DS; Hancox RA; Mulligan KT; Hughes S; Lambe SM; Pringle JH; Walker RA; Jones JL; Shaw JA
Breast Cancer Res; 2010; 12(4):R57. PubMed ID: 20678196
[TBL] [Abstract][Full Text] [Related]
7. Tenascin-C as a prognostic determinant of colorectal cancer through induction of epithelial-to-mesenchymal transition and proliferation.
Yang Z; Zhang C; Qi W; Cui C; Cui Y; Xuan Y
Exp Mol Pathol; 2018 Oct; 105(2):216-222. PubMed ID: 30170017
[TBL] [Abstract][Full Text] [Related]
8. Tenascin-C enhances pancreatic cancer cell growth and motility and affects cell adhesion through activation of the integrin pathway.
Paron I; Berchtold S; Vörös J; Shamarla M; Erkan M; Höfler H; Esposito I
PLoS One; 2011; 6(6):e21684. PubMed ID: 21747918
[TBL] [Abstract][Full Text] [Related]
9. Identification of VEGF-regulated genes associated with increased lung metastatic potential: functional involvement of tenascin-C in tumor growth and lung metastasis.
Calvo A; Catena R; Noble MS; Carbott D; Gil-Bazo I; Gonzalez-Moreno O; Huh JI; Sharp R; Qiu TH; Anver MR; Merlino G; Dickson RB; Johnson MD; Green JE
Oncogene; 2008 Sep; 27(40):5373-84. PubMed ID: 18504437
[TBL] [Abstract][Full Text] [Related]
10. miR-381 inhibited breast cancer cells proliferation, epithelial-to-mesenchymal transition and metastasis by targeting CXCR4.
Xue Y; Xu W; Zhao W; Wang W; Zhang D; Wu P
Biomed Pharmacother; 2017 Feb; 86():426-433. PubMed ID: 28012397
[TBL] [Abstract][Full Text] [Related]
11. Tenascin-c knockdown suppresses vasculogenic mimicry of gastric cancer by inhibiting ERK- triggered EMT.
Kang X; Xu E; Wang X; Qian L; Yang Z; Yu H; Wang C; Ren C; Wang Y; Lu X; Xia X; Guan W; Qiao T
Cell Death Dis; 2021 Sep; 12(10):890. PubMed ID: 34588421
[TBL] [Abstract][Full Text] [Related]
12. PIK3R1 targeting by miR-21 suppresses tumor cell migration and invasion by reducing PI3K/AKT signaling and reversing EMT, and predicts clinical outcome of breast cancer.
Yan LX; Liu YH; Xiang JW; Wu QN; Xu LB; Luo XL; Zhu XL; Liu C; Xu FP; Luo DL; Mei P; Xu J; Zhang KP; Chen J
Int J Oncol; 2016 Feb; 48(2):471-84. PubMed ID: 26676464
[TBL] [Abstract][Full Text] [Related]
13. Tenascin-C is involved in promotion of cancer stemness via the Akt/HIF1ɑ axis in esophageal squamous cell carcinoma.
Yang Z; Zhang C; Feng Y; Qi W; Cui Y; Xuan Y
Exp Mol Pathol; 2019 Aug; 109():104239. PubMed ID: 30904401
[TBL] [Abstract][Full Text] [Related]
14. The monoamine oxidase-A inhibitor clorgyline promotes a mesenchymal-to-epithelial transition in the MDA-MB-231 breast cancer cell line.
Satram-Maharaj T; Nyarko JN; Kuski K; Fehr K; Pennington PR; Truitt L; Freywald A; Lukong KE; Anderson DH; Mousseau DD
Cell Signal; 2014 Dec; 26(12):2621-32. PubMed ID: 25152370
[TBL] [Abstract][Full Text] [Related]
15. Tenascin-C is a potential cancer-associated fibroblasts marker and predicts poor prognosis in prostate cancer.
Ni WD; Yang ZT; Cui CA; Cui Y; Fang LY; Xuan YH
Biochem Biophys Res Commun; 2017 May; 486(3):607-612. PubMed ID: 28341124
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of microRNA-190 inhibits migration, invasion, epithelial-mesenchymal transition, and angiogenesis through suppression of protein kinase B-extracellular signal-regulated kinase signaling pathway via binding to stanniocalicin 2 in breast cancer.
Sun G; Liu M; Han H
J Cell Physiol; 2019 Aug; 234(10):17824-17838. PubMed ID: 30993707
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA signature in the chemoprevention of functionally-enriched stem and progenitor pools (FESPP) by Active Hexose Correlated Compound (AHCC).
Graham ÉA; Mallet JF; Jambi M; Nishioka H; Homma K; Matar C
Cancer Biol Ther; 2017 Oct; 18(10):765-774. PubMed ID: 28886271
[TBL] [Abstract][Full Text] [Related]
18. miR-448 inhibits the epithelial-mesenchymal transition in breast cancer cells by directly targeting the E-cadherin repressor ZEB1/2.
Ma P; Ni K; Ke J; Zhang W; Feng Y; Mao Q
Exp Biol Med (Maywood); 2018 Mar; 243(5):473-480. PubMed ID: 29368542
[TBL] [Abstract][Full Text] [Related]
19. LincK contributes to breast tumorigenesis by promoting proliferation and epithelial-to-mesenchymal transition.
Li J; Hao Y; Mao W; Xue X; Xu P; Liu L; Yuan J; Zhang D; Li N; Chen H; Zhao L; Sun Z; Luo J; Chen R; Zhao RC
J Hematol Oncol; 2019 Feb; 12(1):19. PubMed ID: 30795783
[TBL] [Abstract][Full Text] [Related]
20. Effects of the knockdown of death-associated protein 3 expression on cell adhesion, growth and migration in breast cancer cells.
Wazir U; Sanders AJ; Wazir AM; Ye L; Jiang WG; Ster IC; Sharma AK; Mokbel K
Oncol Rep; 2015 May; 33(5):2575-82. PubMed ID: 25738636
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
